News | October 10, 2025
Thermo Fisher launches new test to assess lung transplant rejection
New gene expression profiling test enhances precision in assessing lung transplant rejection and injury
New gene expression profiling test enhances precision in assessing lung transplant rejection and injury
Lupin's partnership program is designed to foster collaborations with companies looking to extend their product lifecycles
WHO’s global SPECS 2030 target to increase effective refractive error coverage by 40% by 2030
Panacea Biotec receives acceptance from CMSS for supply of bOPV
FineCross M3 empowers physicians to perform safer PCI procedures, helping improve outcomes in patients with challenging coronary anatomies
Positive volume growth was observed in key therapies such as respiratory (13.2% yoy), anti-neoplastics (12.1% yoy) and cardiac (4.8% yoy) during September 2025
Furthering?U.S.-based?pharmaceutical?capacity?to?produce?critical respiratory medicines?
Rifaximin tablets are a rifamycin antibacterial indicated for reducing the risk of overt hepatic encephalopathy
Liothyronine tablets will be manufactured at Zydus' plant in Ahmedabad SEZ
Deflazacort oral suspension is indicated for treating Duchenne Muscular Dystrophy in patients 5 years of age and older
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
